Development and content validation of measures assessing adherence barriers and behaviors for use in clinical care

Dunbar-Jacob, 2001, Treatment adherence in chronic disease, J Clin Epidemiol, 54, S57, 10.1016/S0895-4356(01)00457-7 Haynes, 2000, Interventions for helping patients to follow prescriptions for medications, Cochrane Database Syst Rev, CD000011 DiMatteo, 2004, Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research, Med Care, 42, 200, 10.1097/01.mlr.0000114908.90348.f9 Mazzaglia, 2009, Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients, Circulation, 120, 1598, 10.1161/CIRCULATIONAHA.108.830299 Shalev, 2009, Continuation of statin treatment and all-cause mortality: a population-based cohort study, Arch Intern Med, 169, 260, 10.1001/archinternmed.2008.552 Perreault, 2009, Effect of statin adherence on cerebrovascular disease in primary prevention, Am J Med, 122, 647, 10.1016/j.amjmed.2009.01.032 Perreault, 2009, Impact of better adherence to statin agents in the primary prevention of coronary artery disease, Eur J Clin Pharmacol, 65, 1013, 10.1007/s00228-009-0673-0 Ho, 2008, Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease, Am Heart J, 155, 772, 10.1016/j.ahj.2007.12.011 Horwitz, 1990, Treatment adherence and risk of death after a myocardial infarction, Lancet, 336, 542, 10.1016/0140-6736(90)92095-Y Subotnik, 2011, Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia, Am J Psychiatry, 168, 286, 10.1176/appi.ajp.2010.09010087 Halpern, 2011, The association of adherence to osteoporosis therapies with fracture, all-cause medical costs, and all-cause hospitalizations: a retrospective claims analysis of female health plan enrollees with osteoporosis, J Manag Care Pharm, 17, 25, 10.18553/jmcp.2011.17.1.25 DiMatteo, 2002, Patient adherence and medical treatment outcomes: a meta-analysis, Med Care, 40, 794, 10.1097/00005650-200209000-00009 Hogg, 2002, Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up, AIDS, 16, 1051, 10.1097/00002030-200205030-00012 Wood, 2003, Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L, Ann Intern Med, 139, 810, 10.7326/0003-4819-139-10-200311180-00008 Paterson, 2000, Adherence to protease inhibitor therapy and outcomes in patients with HIV infection, Ann Intern Med, 133, 21, 10.7326/0003-4819-133-1-200007040-00004 Bangsberg, 2000, Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population, AIDS, 14, 357, 10.1097/00002030-200003100-00008 Bangsberg, 2001, Non-adherence to highly active antiretroviral therapy predicts progression to AIDS, AIDS, 15, 1181, 10.1097/00002030-200106150-00015 Bangsberg, 2003, High levels of adherence do not prevent accumulation of HIV drug resistance mutations, AIDS, 17, 1925, 10.1097/00002030-200309050-00011 Garcia de Olalla, 2002, Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients, J Acquir Immune Defic Syndr, 30, 105, 10.1097/00042560-200205010-00014 Mannheimer, 2002, The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials, Clin Infect Dis, 34, 1115, 10.1086/339074 Wood, 2003, Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?, AIDS, 17, 711, 10.1097/00002030-200303280-00009 Sudan, 1998, Causes of late mortality in pediatric liver transplant recipients, Ann Surg, 227, 289, 10.1097/00000658-199802000-00020 Faught, 2008, Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study, Neurology, 71, 1572, 10.1212/01.wnl.0000319693.10338.b9 Ho, 2006, Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus, Arch Intern Med, 166, 1836, 10.1001/archinte.166.17.1836 Gallagher, 1993, The relationship of treatment adherence to the risk of death after myocardial infarction in women, Jama, 270, 742, 10.1001/jama.1993.03510060088038 Health United States, 2012 de Jager, 2017, Medication adherence in patients with apparent resistant hypertension: findings from the SYMPATHY trial, Br J Clin Pharmacol, 84, 18, 10.1111/bcp.13402 Carls, 2017, Understanding the gap between efficacy in randomized controlled trials and effectiveness in real-world use of GLP-1RA and DPP4 therapies in patients with type 2 diabetes, Diabetes Care, 40, 1469, 10.2337/dc16-2725 Edelman, 2017, Type 2 diabetes in the real world: the elusive nature of glycemic control, Diabetes Care, 10.2337/dc16-1974 Gross, 2002, Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy, AIDS, 16, 1835, 10.1097/00002030-200209060-00021 Bangsberg, 2001, Provider assessment of adherence to HIV antiretroviral therapy, J Acquir Immune Defic Syndr, 26, 435, 10.1097/00042560-200104150-00005 Brown, 2011, Medication adherence: WHO cares?, Mayo Clin Proc, 86, 304, 10.4065/mcp.2010.0575 2009 Crane, 2017, HIV provider documentation and actions following patient reports of at-risk behaviors and conditions when identified by a web-based point-of-care assessment, AIDS Behav, 21, 3111, 10.1007/s10461-017-1718-5 Fredericksen, 2014, Attributes of effective patient-reported medication adherence measures across diseases for use with patients with chronic Co-morbidities Fredericksen, 2014, Attributes of effective patient-reported medication adherence measures across diseases for use with patients with chronic Co-morbidities Jensen, 2015, The role of technical advances in the adoption and integration of patient-reported outcomes in clinical care, Med Care, 53, 153, 10.1097/MLR.0000000000000289 Fredericksen, 2012, Integrating a web-based patient assessment into primary care for HIV-infected adults, J AIDS HIV Res, 4 Garfield, 2011, Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review, BMC Med Res Methodol, 11, 149, 10.1186/1471-2288-11-149 Osterberg, 2005, Adherence to medication, N Engl J Med, 353, 487, 10.1056/NEJMra050100 Gordillo, 1999, Sociodemographic and psychological variables influencing adherence to antiretroviral therapy, AIDS, 13, 1763, 10.1097/00002030-199909100-00021 Nieuwkerk, 2001, Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study, Arch Intern Med, 161, 1962, 10.1001/archinte.161.16.1962 Liu, 2001, A comparison study of multiple measures of adherence to HIV protease inhibitors, Ann Intern Med, 134, 968, 10.7326/0003-4819-134-10-200105150-00011 Machtinger, 2005 Cook, 2011, Patterns of change in symptom clusters with human immunodeficiency virus disease progression, J Pain Symptom Manag, 42, 12, 10.1016/j.jpainsymman.2010.09.021 Klem, 2009, Building PROMIS item banks: librarians as co-investigators, Qual Life Res, 18, 881, 10.1007/s11136-009-9498-7 DeWalt, 2007, Evaluation of item candidates: the PROMIS qualitative item review, Med Care, 45, S12, 10.1097/01.mlr.0000254567.79743.e2 Fredericksen, 2018, Development and content validation of a patient-reported sexual risk measure for use in primary care, J Gen Intern Med, 33, 1661, 10.1007/s11606-018-4496-5 Edwards, 2016, Content validity of patient-reported outcomes measurement information system (PROMIS) items in the context of HIV clinical care, Qual Life Res : an international journal of quality of life aspects of treatment, care and rehabilitation, 25, 293, 10.1007/s11136-015-1096-2 Chesney, 2000, Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient care committee & adherence working group of the outcomes committee of the adult AIDS clinical trials group (AACTG), AIDS Care, 12, 255, 10.1080/09540120050042891 Dedoose, 2014 Simoni, 2006, Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management, AIDS Behav, 10, 227, 10.1007/s10461-006-9078-6 Lu, 2008, Optimal recall period and response task for self-reported HIV medication adherence, AIDS Behav, 12, 86, 10.1007/s10461-007-9261-4 Cicchetti, 1994, Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology, Psychol Assess, 6, 284, 10.1037/1040-3590.6.4.284 Fredericksen, 2016, Provider perceptions of the value of same-day, electronic patient-reported measures for use in clinical HIV care, AIDS Care, 1 Menard, 2014, Feasibility and acceptability of the patient-reported outcomes measurement information system measures in children and adolescents in active cancer treatment and survivorship, Cancer Nurs, 37, 66, 10.1097/NCC.0b013e3182a0e23d Stover, 2015, Integrating patient-reported outcome measures into routine cancer care: cancer patients' and clinicians' perceptions of acceptability and value, EGEMS (Wash DC), 3, 1169 Sharma, 2016, Evaluation of point-of-care PRO assessment in clinic settings: integration, parallel-forms reliability, and patient acceptability of electronic QOL measures during clinic visits, Qual Life Res : an international journal of quality of life aspects of treatment, care and rehabilitation, 25, 575, 10.1007/s11136-015-1113-5 Jones, 2014, Acceptability and willingness among men who have sex with men (MSM) to use a tablet-based HIV risk assessment in a clinical setting, SpringerPlus, 3, 708, 10.1186/2193-1801-3-708 Chen, 2013, A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting, BMC Health Serv Res, 13, 211, 10.1186/1472-6963-13-211